Eckert & Ziegler BEBIG, Mick Radio-Nuclear Instruments, WOLF-Medizintechnik (WOmed)

Pressemitteilungen

Wir halten Sie auf dem Laufenden! Wenn Sie Fragen zu unseren Pressemitteilungen haben, können Sie uns gerne über das Kontaktformular der Website kontaktieren. Bleiben Sie über die neuesten Nachrichten unseres Unternehmens auf dem Laufenden:
 
Print

IBt - International Brachytherapy s.a. : IBt - BEBIG wins tender for implants in Spain

IBt - BEBIG wins tender for implants in Spain

IBt - (Reuters: IBTH.BR - Bloomberg: IBTB BB)

Seneffe, Belgium, September 3, 2008.

IBt, the European group specialized in providing seeds used in permanent brachytherapy implants for the treatment of cancer, announces that it has won a large tender to supply IsoCord® to the renowned Madrid cancer research center Hospital Universitario Ramón y Cajal.

This three year contract, for product valued in excess of 0.7 million euros, will further strengthen the position of the company on the Spanish market as a supplier of radiotherapy products. The contract is the fifth long-term supply contract for implants signed with a Spanish hospital since IBt incorporated its Spanish subsidiary earlier this year.

IsoCord® consists of a selectable number of linked seeds used primarily in the treatment of prostate cancer. The IsoCord® system with its convenient and well shielded strand cassette and dispensing device make for quicker procedures and reduced radiation exposure to personnel in the operating room. Long terms study have shown that permanent brachytherapy seed implants provide disease control at least as good as classical radical prostatectomy and external beam radiotherapy but with fewer side effects for patients. Prostate cancer is the commonest form of cancer in men, with about 135,000 new cases diagnosed in Europe every year.

IBt BEBIG Group designs, produces and markets worldwide a complete range of radiotherapy implants used in permanent brachytherapy. The group today includes subsidiaries based in Germany, France, UK, Ireland, Spain, and Italy as well as a large number of distributors spread throughout the world.

Contacts François Blondel, CEO

Laurence Goemaere, Investors Relations Manager

Tel: +32 (0)064.520811

E-mail: ir@ibt.be

Website: www.ibt.be

Back